SAB Biotherapeutics (SABS) Net Margin Growth (1y) (2022 - 2024)
Powered by 
Analysis
SAB Biotherapeutics (SABS) Net Margin Growth (1y) (2022 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -392.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 29,636.00 |
| 10 | SAB Biotherapeutics | 296.68 Mn | 296.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -244,077.00 |
| Jun 30, 2024 | 525,843.00 |
| Mar 31, 2024 | 73,343.00 |
| Dec 31, 2023 | -712,933.00 |
| Sep 30, 2023 | -20,547.00 |
| Jun 30, 2023 | -797,092.00 |
| Mar 31, 2023 | -127,385.00 |
| Dec 31, 2022 | -25,996.00 |
| Sep 30, 2022 | -16,946.00 |
| Jun 30, 2022 | -5,905.00 |
| Mar 31, 2022 | 2.00 |